Recall Register

Food, drugs, devices › Biomerieux Inc

Device recall: The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as a

FDA enforcement event 85209 · Class II · initiated 11 Mar 2020 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordHazelwood, MO

FDA enforcement event 85209 is a device recall by Biomerieux Inc of Hazelwood, MO, initiated 11 Mar 2020 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 916 device enforcement events initiated in 2020 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Biomerieux Inc has 57 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Biomerieux Inc, Hazelwood, MO.

Reason for recall

"There is a potential for the occurrence of false positive OXSF results for some Staphylococcus aureus strains in conjunction with the VITEK 2 AST-P652 test card (ref. 421857, lot 8021232403). ."

Distribution

"No distribution within the United States. Foreign distribution locations: Netherlands, Luxembourg, Belgium"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1742-2020The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in-vitro test to determine susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed.1698 cartons (15,940 cards)Class IIOngoing29 Apr 2020

Context

93%of 2020 device events are Class II916 events that year
1product record in this eventfirm median: 1
57events on this register for the firm

Other enforcement events for Biomerieux Inc

InitiatedProduct (first record)TypeClassRecords
4 Jun 2026VITEK 2 AST-N447 TEST KIT Product reference 424620DeviceClass II1
5 Jan 2026VITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza02n) o MeropenemDeviceClass II1
26 Jun 2025VITEK¿ 2 Gram-negative AST Test Kits (Cards) containing Colistin formulation cs02n. VITEK¿ 2 is an automated system consDeviceClass II1
14 Mar 2024VITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REF 418984; b) ADeviceClass I1
6 Feb 2023MYLA comprises AST Filters in conjunction with VITEK MS; middleware which connects microbiology laboratory instruments fDeviceClass II1
9 Nov 2022API LISTERIA 10 STRIPS+10 MEDIA, CATALOG 10300DeviceClass II94
20 Jul 2022NUCLISENS easyMAG Magnetic Silica, REF 280133, 24 x 1.2mL bottles/kit.DeviceClass II1
13 Jul 2022VITEK 2 / MYLA VITEK 2 Software versions 8.01, 8.02 (veterinary use only), 9.01, 9.02, 9.03 MYLA Software versions V4.8 DeviceClass II1
29 Mar 2022VITEK 2 Systems and VITEK 2 with MYLA.DeviceClass II1
9 Feb 2022VIDAS CMV IgM, 30 tests, REF 30205-01, IVD, Rx.DeviceClass II1

All 57 events for Biomerieux Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "There is a potential for the occurrence of false positive OXSF results for some Staphylococcus aureus strains in conjunction with the VITEK 2 AST-P652 test card (ref. 421857, lot 8021232403). ."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "No distribution within the United States. Foreign distribution locations: Netherlands, Luxembourg, Belgium"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.